BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Innovent Biologics and Sanegene Bio USA Dose First Participant in Phase 1 Trial of Promising siRNA Hypertension Treatment

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

August 02, 2024 | News

Sirnaomics Forms Joint Venture with Gore Range Capital to Propel RNAi Therapeutics into Aesthetic Medicine

Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical co...

August 01, 2024 | News

$2 Million Grant Fuels Queensland Drug Discovery Alliance to Propel Therapeutic Innovations

A $2 million grant awarded to establish the Queensland Drug Discovery Alliance (QDDA) will align and grow Queensland’s small molecule therapeutic dis...

July 31, 2024 | News

Porton Advanced and Geneseed Biotech Forge Strategic Partnership to Accelerate circRNA Therapies

Porton Advanced Solutions ("Porton Advanced") announced that it had reached a strategic cooperation with Guangzhou Geneseed Biotech Co., Ltd ("Geneseed Bio...

July 31, 2024 | News

Akeso's Ivonescimab sBLA Accepted by NMPA for First-Line Treatment of PD-L1 Positive NSCLC

Akeso (9926.HK) is delighted to announce that the supplemental biologics license application (sBLA) for its independently developed, world's first-in-class...

July 30, 2024 | News

Ractigen Therapeutics' RAG-18 Receives FDA Rare Pediatric Disease Designation for Duchenne Muscular Dystrophy

Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, announced that the U.S. Food and Drug Administration (FDA) has ...

July 26, 2024 | News

Sirnaomics Completes IND-Enabling Studies for siRNA Therapeutic STP125G Targeting ApoC3

Sirnaomics Ltd. (the “Company”, Stock Code: 2257.HK, together with its subsidiaries, the “Group” or “Sirnaomics”),...

July 24, 2024 | News

Waters Launches High-Throughput RS-DSC for Biologics Stability Testing

Reduces sample volume requirements by 25x through use of advanced microfluidic technologies while increasing throughput up to 24x compared with competito...

July 24, 2024 | News

Agilent Acquires BIOVECTRA for $925 Million, Expanding Biopharma Capabilities

Agilent Technologies Inc. announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing...

July 23, 2024 | News

Rona Therapeutics Secures $35 Million Series A+ Financing to Advance siRNA Programs

Rona Therapeutics, a clinical stage pioneering platform company in nucleic acid drug research and development, today announced the completion of $35 M...

July 22, 2024 | News

Sanyou Bio and Huadong Medicine Advance SYHD001 ADC Drug to Phase I Clinical Trials

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") has recently announced a significant milestone in collaboration wi...

July 17, 2024 | News

Biosyngen's Groundbreaking CAR-T Therapy BRG01 Approved for Phase II Clinical Trial in China

Biosyngen, a leading biotechnology company focused on the development of innovative cell therapies, recently announced that the Center for Drug Evaluation ...

July 17, 2024 | News

Merck Life Science Launches First GMP Compliant Manufacturing Line for Cell Culture Media in China

Merck Life Science is thrilled to announce the commencement of commercial production at our first Good Manufacturing Practice (GMP) compliant manuf...

July 16, 2024 | News

Nona Biosciences and Alaya.bio Announce Collaboration to Revolutionize CAR-T Cell Therapy Development

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody disc...

July 15, 2024 | News

Stay Connected